• Return to Headlines

Relatively Low P/E Ratio Detected in Shares of Ophth0Tech Corp in the Biotechnology Industry (OPHT, CNCE, PDLI, UTHR, ACOR)

By David Diaz

Below are the three companies in the Biotechnology industry with the lowest price to earnings (P/E) ratios. P/E is an important valuation tool when comparing companies in the same industry. A higher P/E ratio means that investors are paying more for each unit of net income, so the stock is more expensive compared to one with a lower P/E ratio.

Ophth0Tech Corp ranks lowest with a a P/E ratio of 0.35. Concert Pharmace is next with a a P/E ratio of 1.39. Pdl Biopharma In ranks third lowest with a a P/E ratio of 4.85.

United Therapeut follows with a a P/E ratio of 4.90, and Acorda Therapeut rounds out the bottom five with a a P/E ratio of 7.02.

SmarTrend is tracking the current trend status for Acorda Therapeut and will alert subscribers who have ACOR in their portfolio or watchlist when shares have changed trend direction.

Keywords: lowest p/e ratio ophth0tech corp concert pharmace pdl biopharma in united therapeut acorda therapeut

Ticker(s): OPHT CNCE PDLI UTHR ACOR